| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| TFX - Teleflex Incorporated | SELL | -25 @ 139.75 | -3,494 | The ETF sold 25 shares of TFX on 2025-03-17. The shares were previously bought for an average price of 186.679. The Teleflex Incorporated shares were sold for -25.1% lower than average price of previous purchases. This resulted in an overall loss of 1,173 The average price that the ETF previously sold TFX share for is so the ETF has sold 25 shares on 2025-03-17 at a higher price than the previous selling average. |
| DVA - DaVita HealthCare Partners Inc | SELL | -25 @ USD 149.24 | USD -3,731 | The ETF sold 25 shares of DVA on 2025-03-17. The shares were previously bought for an average price of USD 157.571. The DaVita HealthCare Partners Inc shares were sold for -5.3% lower than average price of previous purchases. This resulted in an overall loss of USD 208 The average price that the ETF previously sold DVA share for is USD so the ETF has sold 25 shares on 2025-03-17 at a higher price than the previous selling average. |
| CRL - Creightons Plc | SELL | -28 @ USD 175.01 | USD -4,900 | The ETF sold 28 shares of CRL on 2025-03-17. The shares were previously bought for an average price of USD 174.583. The Creightons Plc shares were sold for 0.2% higher than average price of previous purchases. This sale made a profit of USD 12 The average price that the ETF previously sold CRL share for is USD so the ETF has sold 28 shares on 2025-03-17 at a higher price than the previous selling average. |
| HSIC - Henry Schein Inc | SELL | -69 @ USD 71.8 | USD -4,954 | The ETF sold 69 shares of HSIC on 2025-03-17. The shares were previously bought for an average price of USD 74.8461. The Henry Schein Inc shares were sold for -4.1% lower than average price of previous purchases. This resulted in an overall loss of USD 210 The average price that the ETF previously sold HSIC share for is USD so the ETF has sold 69 shares on 2025-03-17 at a higher price than the previous selling average. |
| TECH - Bio-Techne Corp | SELL | -86 @ USD 62.58 | USD -5,382 | The ETF sold 86 shares of TECH on 2025-03-17. The shares were previously bought for an average price of USD 69.0828. The Bio-Techne Corp shares were sold for -9.4% lower than average price of previous purchases. This resulted in an overall loss of USD 559 The average price that the ETF previously sold TECH share for is USD so the ETF has sold 86 shares on 2025-03-17 at a higher price than the previous selling average. |
| UHS - Universal Health Services Inc | SELL | -31 @ USD 174.58 | USD -5,412 | The ETF sold 31 shares of UHS on 2025-03-17. The shares were previously bought for an average price of USD 193.396. The Universal Health Services Inc shares were sold for -9.7% lower than average price of previous purchases. This resulted in an overall loss of USD 583 The average price that the ETF previously sold UHS share for is USD so the ETF has sold 31 shares on 2025-03-17 at a higher price than the previous selling average. |
| INCY - Incyte Corporation | SELL | -88 @ USD 62.01 | USD -5,457 | The ETF sold 88 shares of INCY on 2025-03-17. The shares were previously bought for an average price of USD 71.8161. The Incyte Corporation shares were sold for -13.7% lower than average price of previous purchases. This resulted in an overall loss of USD 863 The average price that the ETF previously sold INCY share for is USD so the ETF has sold 88 shares on 2025-03-17 at a higher price than the previous selling average. |
| SOLV - Solventum Corp. | SELL | -74 @ USD 75.15 | USD -5,561 | The ETF sold 74 shares of SOLV on 2025-03-17. The shares were previously bought for an average price of USD 74.6879. The Solventum Corp. shares were sold for 0.6% higher than average price of previous purchases. This sale made a profit of USD 34 The average price that the ETF previously sold SOLV share for is USD so the ETF has sold 74 shares on 2025-03-17 at a higher price than the previous selling average. |
| VTRS - Viatris Inc | SELL | -663 @ USD 9.25 | USD -6,133 | The ETF sold 663 shares of VTRS on 2025-03-17. The shares were previously bought for an average price of USD 10.9522. The Viatris Inc shares were sold for -15.5% lower than average price of previous purchases. This resulted in an overall loss of USD 1,129 The average price that the ETF previously sold VTRS share for is USD so the ETF has sold 663 shares on 2025-03-17 at a higher price than the previous selling average. |
| MRNA - Moderna Inc | SELL | -183 @ USD 34.71 | USD -6,352 | The ETF sold 183 shares of MRNA on 2025-03-17. The shares were previously bought for an average price of USD 38.499. The Moderna Inc shares were sold for -9.8% lower than average price of previous purchases. This resulted in an overall loss of USD 693 The average price that the ETF previously sold MRNA share for is USD so the ETF has sold 183 shares on 2025-03-17 at a higher price than the previous selling average. |
| ALGN - Align Technology Inc | SELL | -39 @ USD 169.59 | USD -6,614 | The ETF sold 39 shares of ALGN on 2025-03-17. The shares were previously bought for an average price of USD 195.581. The Align Technology Inc shares were sold for -13.3% lower than average price of previous purchases. This resulted in an overall loss of USD 1,014 The average price that the ETF previously sold ALGN share for is USD so the ETF has sold 39 shares on 2025-03-17 at a higher price than the previous selling average. |
| RVTY - Revvity Inc. | SELL | -67 @ USD 113.21 | USD -7,585 | The ETF sold 67 shares of RVTY on 2025-03-17. The shares were previously bought for an average price of USD 115.452. The Revvity Inc. shares were sold for -1.9% lower than average price of previous purchases. This resulted in an overall loss of USD 150 The average price that the ETF previously sold RVTY share for is USD so the ETF has sold 67 shares on 2025-03-17 at a higher price than the previous selling average. |
| HOLX - Hologic Inc | SELL | -128 @ USD 61.82 | USD -7,913 | The ETF sold 128 shares of HOLX on 2025-03-17. The shares were previously bought for an average price of USD 68.8764. The Hologic Inc shares were sold for -10.2% lower than average price of previous purchases. This resulted in an overall loss of USD 903 The average price that the ETF previously sold HOLX share for is USD so the ETF has sold 128 shares on 2025-03-17 at a higher price than the previous selling average. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -107 @ USD 79.91 | USD -8,550 | The ETF sold 107 shares of COO on 2025-03-17. The shares were previously bought for an average price of USD 95.6913. The The Cooper Companies, Inc. Common Stock shares were sold for -16.5% lower than average price of previous purchases. This resulted in an overall loss of USD 1,689 The average price that the ETF previously sold COO share for is USD so the ETF has sold 107 shares on 2025-03-17 at a higher price than the previous selling average. |
| WST - West Pharmaceutical Services Inc | SELL | -39 @ USD 231.46 | USD -9,027 | The ETF sold 39 shares of WST on 2025-03-17. The shares were previously bought for an average price of USD 273.229. The West Pharmaceutical Services Inc shares were sold for -15.3% lower than average price of previous purchases. This resulted in an overall loss of USD 1,629 The average price that the ETF previously sold WST share for is USD so the ETF has sold 39 shares on 2025-03-17 at a higher price than the previous selling average. |
| BAX - Baxter International Inc | SELL | -277 @ USD 34.85 | USD -9,653 | The ETF sold 277 shares of BAX on 2025-03-17. The shares were previously bought for an average price of USD 33.5907. The Baxter International Inc shares were sold for 3.7% higher than average price of previous purchases. This sale made a profit of USD 349 The average price that the ETF previously sold BAX share for is USD so the ETF has sold 277 shares on 2025-03-17 at a higher price than the previous selling average. |
| MOH - MOH | SELL | -31 @ USD 315.97 | USD -9,795 | The ETF sold 31 shares of MOH on 2025-03-17. The shares were previously bought for an average price of USD 304.261. The MOH shares were sold for 3.8% higher than average price of previous purchases. This sale made a profit of USD 363 The average price that the ETF previously sold MOH share for is USD so the ETF has sold 31 shares on 2025-03-17 at a higher price than the previous selling average. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -31 @ USD 315.97 | USD -9,795 | The ETF sold 31 shares of MOH on 2025-03-17. The shares were previously bought for an average price of USD 304.261. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for 3.8% higher than average price of previous purchases. This sale made a profit of USD 363 The average price that the ETF previously sold MOH share for is USD so the ETF has sold 31 shares on 2025-03-17 at a higher price than the previous selling average. |
| PODD - Insulet Corporation | SELL | -38 @ USD 261.63 | USD -9,942 | The ETF sold 38 shares of PODD on 2025-03-17. The shares were previously bought for an average price of USD 270.492. The Insulet Corporation shares were sold for -3.3% lower than average price of previous purchases. This resulted in an overall loss of USD 337 The average price that the ETF previously sold PODD share for is USD so the ETF has sold 38 shares on 2025-03-17 at a higher price than the previous selling average. |
| DGX - Quest Diagnostics Incorporated | SELL | -61 @ USD 173.48 | USD -10,582 | The ETF sold 61 shares of DGX on 2025-03-17. The shares were previously bought for an average price of USD 165.838. The Quest Diagnostics Incorporated shares were sold for 4.6% higher than average price of previous purchases. This sale made a profit of USD 466 The average price that the ETF previously sold DGX share for is USD so the ETF has sold 61 shares on 2025-03-17 at a higher price than the previous selling average. |
| LH - Laboratory Corporation of America Holdings | SELL | -45 @ USD 240.43 | USD -10,819 | The ETF sold 45 shares of LH on 2025-03-17. The shares were previously bought for an average price of USD 244.451. The Laboratory Corporation of America Holdings shares were sold for -1.6% lower than average price of previous purchases. This resulted in an overall loss of USD 181 The average price that the ETF previously sold LH share for is USD so the ETF has sold 45 shares on 2025-03-17 at a higher price than the previous selling average. |
| BIIB - Biogen Inc | SELL | -79 @ USD 143.54 | USD -11,340 | The ETF sold 79 shares of BIIB on 2025-03-17. The shares were previously bought for an average price of USD 152.292. The Biogen Inc shares were sold for -5.7% lower than average price of previous purchases. This resulted in an overall loss of USD 691 The average price that the ETF previously sold BIIB share for is USD so the ETF has sold 79 shares on 2025-03-17 at a higher price than the previous selling average. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -107 @ USD 111.79 | USD -11,962 | The ETF sold 107 shares of ZBH on 2025-03-17. The shares were previously bought for an average price of USD 106.571. The Zimmer Biomet Holdings Inc shares were sold for 4.9% higher than average price of previous purchases. This sale made a profit of USD 558 The average price that the ETF previously sold ZBH share for is USD so the ETF has sold 107 shares on 2025-03-17 at a higher price than the previous selling average. |
| WAT - Waters Corporation | SELL | -32 @ USD 378.92 | USD -12,125 | The ETF sold 32 shares of WAT on 2025-03-17. The shares were previously bought for an average price of USD 375.637. The Waters Corporation shares were sold for 0.9% higher than average price of previous purchases. This sale made a profit of USD 105 The average price that the ETF previously sold WAT share for is USD so the ETF has sold 32 shares on 2025-03-17 at a higher price than the previous selling average. |
| WAT - MULETFWATIMETFP | SELL | -32 @ USD 378.92 | USD -12,125 | The ETF sold 32 shares of WAT on 2025-03-17. The shares were previously bought for an average price of USD 375.637. The MULETFWATIMETFP shares were sold for 0.9% higher than average price of previous purchases. This sale made a profit of USD 105 The average price that the ETF previously sold WAT share for is USD so the ETF has sold 32 shares on 2025-03-17 at a higher price than the previous selling average. |
| STE - STERIS plc | SELL | -54 @ USD 227.81 | USD -12,302 | The ETF sold 54 shares of STE on 2025-03-17. The shares were previously bought for an average price of USD 221.198. The STERIS plc shares were sold for 3.0% higher than average price of previous purchases. This sale made a profit of USD 357 The average price that the ETF previously sold STE share for is USD so the ETF has sold 54 shares on 2025-03-17 at a higher price than the previous selling average. |
| MTD - Mettler-Toledo International Inc | SELL | -11 @ USD 1235.02 | USD -13,585 | The ETF sold 11 shares of MTD on 2025-03-17. The shares were previously bought for an average price of USD 1281.94. The Mettler-Toledo International Inc shares were sold for -3.7% lower than average price of previous purchases. This resulted in an overall loss of USD 516 The average price that the ETF previously sold MTD share for is USD so the ETF has sold 11 shares on 2025-03-17 at a higher price than the previous selling average. |
| MTD - AMUNDI EUR GOV 710 | SELL | -11 @ USD 1235.02 | USD -13,585 | The ETF sold 11 shares of MTD on 2025-03-17. The shares were previously bought for an average price of USD 1281.94. The AMUNDI EUR GOV 710 shares were sold for -3.7% lower than average price of previous purchases. This resulted in an overall loss of USD 516 The average price that the ETF previously sold MTD share for is USD so the ETF has sold 11 shares on 2025-03-17 at a higher price than the previous selling average. |
| DXCM - DexCom Inc | SELL | -211 @ USD 71.35 | USD -15,055 | The ETF sold 211 shares of DXCM on 2025-03-17. The shares were previously bought for an average price of USD 81.6828. The DexCom Inc shares were sold for -12.6% lower than average price of previous purchases. This resulted in an overall loss of USD 2,180 The average price that the ETF previously sold DXCM share for is USD so the ETF has sold 211 shares on 2025-03-17 at a higher price than the previous selling average. |
| CNC - Concurrent Technologies Plc | SELL | -272 @ USD 59.24 | USD -16,113 | The ETF sold 272 shares of CNC on 2025-03-17. The shares were previously bought for an average price of USD 60.0999. The Concurrent Technologies Plc shares were sold for -1.4% lower than average price of previous purchases. This resulted in an overall loss of USD 234 The average price that the ETF previously sold CNC share for is USD so the ETF has sold 272 shares on 2025-03-17 at a higher price than the previous selling average. |
| CAH - Cardinal Health Inc | SELL | -130 @ USD 130.03 | USD -16,904 | The ETF sold 130 shares of CAH on 2025-03-17. The shares were previously bought for an average price of USD 123.494. The Cardinal Health Inc shares were sold for 5.3% higher than average price of previous purchases. This sale made a profit of USD 850 The average price that the ETF previously sold CAH share for is USD so the ETF has sold 130 shares on 2025-03-17 at a higher price than the previous selling average. |
| HUM - Hummingbird Resources PLC | SELL | -65 @ USD 264.41 | USD -17,187 | The ETF sold 65 shares of HUM on 2025-03-17. The shares were previously bought for an average price of USD 273.627. The Hummingbird Resources PLC shares were sold for -3.4% lower than average price of previous purchases. This resulted in an overall loss of USD 599 The average price that the ETF previously sold HUM share for is USD so the ETF has sold 65 shares on 2025-03-17 at a higher price than the previous selling average. |
| HUM - Humana Inc | SELL | -65 @ USD 264.41 | USD -17,187 | The ETF sold 65 shares of HUM on 2025-03-17. The shares were previously bought for an average price of USD 273.627. The Humana Inc shares were sold for -3.4% lower than average price of previous purchases. This resulted in an overall loss of USD 599 The average price that the ETF previously sold HUM share for is USD so the ETF has sold 65 shares on 2025-03-17 at a higher price than the previous selling average. |
| IQV - IQVIA Holdings Inc | SELL | -93 @ USD 184.9 | USD -17,196 | The ETF sold 93 shares of IQV on 2025-03-17. The shares were previously bought for an average price of USD 200.874. The IQVIA Holdings Inc shares were sold for -8.0% lower than average price of previous purchases. This resulted in an overall loss of USD 1,486 The average price that the ETF previously sold IQV share for is USD so the ETF has sold 93 shares on 2025-03-17 at a higher price than the previous selling average. |
| RMD - ResMed Inc | SELL | -80 @ USD 224.74 | USD -17,979 | The ETF sold 80 shares of RMD on 2025-03-17. The shares were previously bought for an average price of USD 238.918. The ResMed Inc shares were sold for -5.9% lower than average price of previous purchases. This resulted in an overall loss of USD 1,134 The average price that the ETF previously sold RMD share for is USD so the ETF has sold 80 shares on 2025-03-17 at a higher price than the previous selling average. |
| IDXX - IDEXX Laboratories Inc | SELL | -44 @ USD 422.36 | USD -18,584 | The ETF sold 44 shares of IDXX on 2025-03-17. The shares were previously bought for an average price of USD 445.288. The IDEXX Laboratories Inc shares were sold for -5.1% lower than average price of previous purchases. This resulted in an overall loss of USD 1,009 The average price that the ETF previously sold IDXX share for is USD so the ETF has sold 44 shares on 2025-03-17 at a higher price than the previous selling average. |
| A - Agilent Technologies Inc | SELL | -155 @ USD 122.49 | USD -18,986 | The ETF sold 155 shares of A on 2025-03-17. The shares were previously bought for an average price of USD 135.776. The Agilent Technologies Inc shares were sold for -9.8% lower than average price of previous purchases. This resulted in an overall loss of USD 2,059 The average price that the ETF previously sold A share for is USD so the ETF has sold 155 shares on 2025-03-17 at a higher price than the previous selling average. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -247 @ USD 82.47 | USD -20,370 | The ETF sold 247 shares of GEHC on 2025-03-17. The shares were previously bought for an average price of USD 88.3706. The GE HealthCare Technologies Inc. shares were sold for -6.7% lower than average price of previous purchases. This resulted in an overall loss of USD 1,457 The average price that the ETF previously sold GEHC share for is USD so the ETF has sold 247 shares on 2025-03-17 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -318 @ USD 70.63 | USD -22,460 | The ETF sold 318 shares of EW on 2025-03-17. The shares were previously bought for an average price of USD 71.1513. The Edwards Lifesciences Corp shares were sold for -0.7% lower than average price of previous purchases. This resulted in an overall loss of USD 166 The average price that the ETF previously sold EW share for is USD so the ETF has sold 318 shares on 2025-03-17 at a higher price than the previous selling average. |
| COR - Cencora Inc. | SELL | -95 @ USD 260.96 | USD -24,791 | The ETF sold 95 shares of COR on 2025-03-17. The shares were previously bought for an average price of USD 245.745. The Cencora Inc. shares were sold for 6.2% higher than average price of previous purchases. This sale made a profit of USD 1,445 The average price that the ETF previously sold COR share for is USD so the ETF has sold 95 shares on 2025-03-17 at a higher price than the previous selling average. |
| HCA - HCA Holdings Inc | SELL | -99 @ USD 328.46 | USD -32,518 | The ETF sold 99 shares of HCA on 2025-03-17. The shares were previously bought for an average price of USD 335.917. The HCA Holdings Inc shares were sold for -2.2% lower than average price of previous purchases. This resulted in an overall loss of USD 738 The average price that the ETF previously sold HCA share for is USD so the ETF has sold 99 shares on 2025-03-17 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -156 @ USD 227.83 | USD -35,541 | The ETF sold 156 shares of BDX on 2025-03-17. The shares were previously bought for an average price of USD 231.66. The Becton Dickinson and Company shares were sold for -1.7% lower than average price of previous purchases. This resulted in an overall loss of USD 597 The average price that the ETF previously sold BDX share for is USD so the ETF has sold 156 shares on 2025-03-17 at a higher price than the previous selling average. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -57 @ USD 678.42 | USD -38,670 | The ETF sold 57 shares of REGN on 2025-03-17. The shares were previously bought for an average price of USD 748.541. The Regeneron Pharmaceuticals Inc shares were sold for -9.4% lower than average price of previous purchases. This resulted in an overall loss of USD 3,997 The average price that the ETF previously sold REGN share for is USD so the ETF has sold 57 shares on 2025-03-17 at a higher price than the previous selling average. |
| ZTS - Zoetis Inc | SELL | -245 @ USD 165.17 | USD -40,467 | The ETF sold 245 shares of ZTS on 2025-03-17. The shares were previously bought for an average price of USD 169.983. The Zoetis Inc shares were sold for -2.8% lower than average price of previous purchases. This resulted in an overall loss of USD 1,179 The average price that the ETF previously sold ZTS share for is USD so the ETF has sold 245 shares on 2025-03-17 at a higher price than the previous selling average. |
| MCK - McKesson Corporation | SELL | -69 @ USD 655.25 | USD -45,212 | The ETF sold 69 shares of MCK on 2025-03-17. The shares were previously bought for an average price of USD 599.489. The McKesson Corporation shares were sold for 9.3% higher than average price of previous purchases. This sale made a profit of USD 3,848 The average price that the ETF previously sold MCK share for is USD so the ETF has sold 69 shares on 2025-03-17 at a higher price than the previous selling average. |
| CVS - CVS Health Corp | SELL | -681 @ USD 66.65 | USD -45,389 | The ETF sold 681 shares of CVS on 2025-03-17. The shares were previously bought for an average price of USD 60.4257. The CVS Health Corp shares were sold for 10.3% higher than average price of previous purchases. This sale made a profit of USD 4,239 The average price that the ETF previously sold CVS share for is USD so the ETF has sold 681 shares on 2025-03-17 at a higher price than the previous selling average. |
| CI - Cigna Corp | SELL | -151 @ USD 316.8 | USD -47,837 | The ETF sold 151 shares of CI on 2025-03-17. The shares were previously bought for an average price of USD 312.15. The Cigna Corp shares were sold for 1.5% higher than average price of previous purchases. This sale made a profit of USD 702 The average price that the ETF previously sold CI share for is USD so the ETF has sold 151 shares on 2025-03-17 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -125 @ USD 430.59 | USD -53,824 | The ETF sold 125 shares of ELV on 2025-03-17. The shares were previously bought for an average price of USD 402.989. The Elevance Health Inc shares were sold for 6.8% higher than average price of previous purchases. This sale made a profit of USD 3,450 The average price that the ETF previously sold ELV share for is USD so the ETF has sold 125 shares on 2025-03-17 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -125 @ USD 430.59 | USD -53,824 | The ETF sold 125 shares of ELV on 2025-03-17. The shares were previously bought for an average price of USD 402.989. The Elevance Health Inc shares were sold for 6.8% higher than average price of previous purchases. This sale made a profit of USD 3,450 The average price that the ETF previously sold ELV share for is USD so the ETF has sold 125 shares on 2025-03-17 at a higher price than the previous selling average. |
| MDT - Medtronic PLC | SELL | -694 @ USD 93.35 | USD -64,785 | The ETF sold 694 shares of MDT on 2025-03-17. The shares were previously bought for an average price of USD 89.0218. The Medtronic PLC shares were sold for 4.9% higher than average price of previous purchases. This sale made a profit of USD 3,004 The average price that the ETF previously sold MDT share for is USD so the ETF has sold 694 shares on 2025-03-17 at a higher price than the previous selling average. |
| BMY - Bloomsbury Publishing Plc | SELL | -1,098 @ USD 59.99 | USD -65,869 | The ETF sold 1098 shares of BMY on 2025-03-17. The shares were previously bought for an average price of USD 57.2428. The Bloomsbury Publishing Plc shares were sold for 4.8% higher than average price of previous purchases. This sale made a profit of USD 3,016 The average price that the ETF previously sold BMY share for is USD so the ETF has sold 1098 shares on 2025-03-17 at a higher price than the previous selling average. |
| SYK - Stryker Corporation | SELL | -186 @ USD 373.49 | USD -69,469 | The ETF sold 186 shares of SYK on 2025-03-17. The shares were previously bought for an average price of USD 384.026. The Stryker Corporation shares were sold for -2.7% lower than average price of previous purchases. This resulted in an overall loss of USD 1,960 The average price that the ETF previously sold SYK share for is USD so the ETF has sold 186 shares on 2025-03-17 at a higher price than the previous selling average. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -139 @ USD 513.76 | USD -71,413 | The ETF sold 139 shares of VRTX on 2025-03-17. The shares were previously bought for an average price of USD 473.58. The Vertex Pharmaceuticals Inc shares were sold for 8.5% higher than average price of previous purchases. This sale made a profit of USD 5,585 The average price that the ETF previously sold VRTX share for is USD so the ETF has sold 139 shares on 2025-03-17 at a higher price than the previous selling average. |
| DHR - Danaher Corporation | SELL | -348 @ USD 212.6 | USD -73,985 | The ETF sold 348 shares of DHR on 2025-03-17. The shares were previously bought for an average price of USD 223.215. The Danaher Corporation shares were sold for -4.8% lower than average price of previous purchases. This resulted in an overall loss of USD 3,694 The average price that the ETF previously sold DHR share for is USD so the ETF has sold 348 shares on 2025-03-17 at a higher price than the previous selling average. |
| DHR - Danaher Corporation | SELL | -348 @ USD 212.6 | USD -73,985 | The ETF sold 348 shares of DHR on 2025-03-17. The shares were previously bought for an average price of USD 223.215. The Danaher Corporation shares were sold for -4.8% lower than average price of previous purchases. This resulted in an overall loss of USD 3,694 The average price that the ETF previously sold DHR share for is USD so the ETF has sold 348 shares on 2025-03-17 at a higher price than the previous selling average. |
| GILD - Guild Esports Plc | SELL | -674 @ USD 112.26 | USD -75,663 | The ETF sold 674 shares of GILD on 2025-03-17. The shares were previously bought for an average price of USD 100.593. The Guild Esports Plc shares were sold for 11.6% higher than average price of previous purchases. This sale made a profit of USD 7,864 The average price that the ETF previously sold GILD share for is USD so the ETF has sold 674 shares on 2025-03-17 at a higher price than the previous selling average. |
| BSX - Boston Scientific Corporation | SELL | -798 @ USD 98.9 | USD -78,922 | The ETF sold 798 shares of BSX on 2025-03-17. The shares were previously bought for an average price of USD 97.3607. The Boston Scientific Corporation shares were sold for 1.6% higher than average price of previous purchases. This sale made a profit of USD 1,228 The average price that the ETF previously sold BSX share for is USD so the ETF has sold 798 shares on 2025-03-17 at a higher price than the previous selling average. |
| BSX - MULSTRXSSXIMETFP | SELL | -798 @ USD 98.9 | USD -78,922 | The ETF sold 798 shares of BSX on 2025-03-17. The shares were previously bought for an average price of USD 97.3607. The MULSTRXSSXIMETFP shares were sold for 1.6% higher than average price of previous purchases. This sale made a profit of USD 1,228 The average price that the ETF previously sold BSX share for is USD so the ETF has sold 798 shares on 2025-03-17 at a higher price than the previous selling average. |
| PFE - Pfizer Inc | SELL | -3,068 @ USD 26.05 | USD -79,921 | The ETF sold 3068 shares of PFE on 2025-03-17. The shares were previously bought for an average price of USD 26.291. The Pfizer Inc shares were sold for -0.9% lower than average price of previous purchases. This resulted in an overall loss of USD 739 The average price that the ETF previously sold PFE share for is USD so the ETF has sold 3068 shares on 2025-03-17 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -291 @ USD 317.17 | USD -92,296 | The ETF sold 291 shares of AMGN on 2025-03-17. The shares were previously bought for an average price of USD 303.185. The Amgen Inc shares were sold for 4.6% higher than average price of previous purchases. This sale made a profit of USD 4,070 The average price that the ETF previously sold AMGN share for is USD so the ETF has sold 291 shares on 2025-03-17 at a higher price than the previous selling average. |
| ISRG - Intuitive Surgical Inc | SELL | -193 @ USD 488.8 | USD -94,338 | The ETF sold 193 shares of ISRG on 2025-03-17. The shares were previously bought for an average price of USD 564.855. The Intuitive Surgical Inc shares were sold for -13.5% lower than average price of previous purchases. This resulted in an overall loss of USD 14,679 The average price that the ETF previously sold ISRG share for is USD so the ETF has sold 193 shares on 2025-03-17 at a higher price than the previous selling average. |
| TMO - Time Out Group plc | SELL | -207 @ USD 519.57 | USD -107,551 | The ETF sold 207 shares of TMO on 2025-03-17. The shares were previously bought for an average price of USD 542.415. The Time Out Group plc shares were sold for -4.2% lower than average price of previous purchases. This resulted in an overall loss of USD 4,729 The average price that the ETF previously sold TMO share for is USD so the ETF has sold 207 shares on 2025-03-17 at a higher price than the previous selling average. |
| ABT - Abbott Laboratories | SELL | -938 @ USD 127.64 | USD -119,726 | The ETF sold 938 shares of ABT on 2025-03-17. The shares were previously bought for an average price of USD 125.806. The Abbott Laboratories shares were sold for 1.5% higher than average price of previous purchases. This sale made a profit of USD 1,720 The average price that the ETF previously sold ABT share for is USD so the ETF has sold 938 shares on 2025-03-17 at a higher price than the previous selling average. |
| MRK - Marks Electrical Group PLC | SELL | -1,369 @ USD 94.79 | USD -129,768 | The ETF sold 1369 shares of MRK on 2025-03-17. The shares were previously bought for an average price of USD 93.9678. The Marks Electrical Group PLC shares were sold for 0.9% higher than average price of previous purchases. This sale made a profit of USD 1,126 The average price that the ETF previously sold MRK share for is USD so the ETF has sold 1369 shares on 2025-03-17 at a higher price than the previous selling average. |
| MRK - Merck & Company Inc | SELL | -1,369 @ USD 94.79 | USD -129,768 | The ETF sold 1369 shares of MRK on 2025-03-17. The shares were previously bought for an average price of USD 93.9678. The Merck & Company Inc shares were sold for 0.9% higher than average price of previous purchases. This sale made a profit of USD 1,126 The average price that the ETF previously sold MRK share for is USD so the ETF has sold 1369 shares on 2025-03-17 at a higher price than the previous selling average. |
| ABBV - AbbVie Inc | SELL | -956 @ USD 214.47 | USD -205,033 | The ETF sold 956 shares of ABBV on 2025-03-17. The shares were previously bought for an average price of USD 188.676. The AbbVie Inc shares were sold for 13.7% higher than average price of previous purchases. This sale made a profit of USD 24,659 The average price that the ETF previously sold ABBV share for is USD so the ETF has sold 956 shares on 2025-03-17 at a higher price than the previous selling average. |
| JNJ - Johnson & Johnson | SELL | -1,303 @ USD 162.84 | USD -212,181 | The ETF sold 1303 shares of JNJ on 2025-03-17. The shares were previously bought for an average price of USD 157.816. The Johnson & Johnson shares were sold for 3.2% higher than average price of previous purchases. This sale made a profit of USD 6,546 The average price that the ETF previously sold JNJ share for is USD so the ETF has sold 1303 shares on 2025-03-17 at a higher price than the previous selling average. |
| UNH - UnitedHealth Group Incorporated | SELL | -498 @ USD 499.02 | USD -248,512 | The ETF sold 498 shares of UNH on 2025-03-17. The shares were previously bought for an average price of USD 543.454. The UnitedHealth Group Incorporated shares were sold for -8.2% lower than average price of previous purchases. This resulted in an overall loss of USD 22,128 The average price that the ETF previously sold UNH share for is USD so the ETF has sold 498 shares on 2025-03-17 at a higher price than the previous selling average. |
| LLY - Eli Lilly and Company | SELL | -426 @ USD 824.76 | USD -351,348 | The ETF sold 426 shares of LLY on 2025-03-17. The shares were previously bought for an average price of USD 848.935. The Eli Lilly and Company shares were sold for -2.8% lower than average price of previous purchases. This resulted in an overall loss of USD 10,299 The average price that the ETF previously sold LLY share for is USD so the ETF has sold 426 shares on 2025-03-17 at a higher price than the previous selling average. |